National guidelines for the management of absolute cardiovascular disease risk

Medical Journal of Australia

Volumn 199, Issue 4, 2013, Pages 243-244

  Usherwood, Timothy ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; TELMISARTAN; THIAZIDE DIURETIC AGENT;

AUSTRALIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMBINATION CHEMOTHERAPY; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG SAFETY; EVIDENCE BASED PRACTICE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; LETTER; LOW DRUG DOSE; META ANALYSIS (TOPIC); MONOTHERAPY; MORTALITY; PRACTICE GUIDELINE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUSTRALIA; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; DIURETICS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE HEALTH SERVICES; PRIMARY HEALTH CARE;

EID: 84882238565     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.10248     Document Type: Letter

References (7)

1. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. Canberra: National Vascular Disease Prevention Alliance, 2012. http://strokefoundation.com.au/site/media/ AbsoluteCVD_GL_webready.pdf (accessed Feb 2013).
2. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559.
3. Makani H, Bangalore S, Desouza KA, et al. Efficacy and safety of dual blockade of the reninangiotensin system: meta-analysis of randomised trials. BMJ 2013; 346: f360
4. National Clinical Guideline Centre. Hypertension. Clinical management of primary hypertension in adults. NICE clinical guideline 127. London: National Clinical Guideline Centre, 2011.
5. Hypertension Canada. Hypertension without compelling indications. 2013 CHEP recommendations. http://www.hypertension.ca/ recommendation-details (accessed Feb 2013).
6. Kidney Health Australia. Chronic kidney disease (CKD) management in general practice. 2nd ed. Melbourne: Kidney Health Australia, 2012.
7. National Aboriginal Community Controlled Health Organisation and Royal Australian College of General Practitioners. National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people. 2nd ed. Melbourne: RACGP, 2012.